H1/NK1 antagonists (Inflazyme)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameH1/NK1 antagonists (Inflazyme)
Drug Alias NameMDL-103896MDL-108207DA
ClassificationSmall molecules
Mechanisms of ActionNeurokinin 1 receptor antagonistsHistamine H1 receptor antagonists
TargetsNeurokinin 1 receptorHistamine H1 receptor
Therapy Area/IndicationsHypersensitivityEye DiseasesRhinitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAventis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHoechst Marion Roussel LtdInflazyme Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsHypersensitivityEye DiseasesRhinitis, Allergic

Other Information

ATC CodeN/A
Related LinksN/A